FREE Case Review (866) 588-0600

Risperdal Lawsuit Louisiana

A lawsuit has been filed in Louisiana federal court on behalf of a man who allegedly suffered abnormal breast growth after taking Risperdal.

A lawsuit has been filed in Louisiana federal court on behalf of a man who allegedly suffered abnormal breast growth, a condition known as gynecomastia, after taking Risperdal (generic: risperidone) to treat the symptoms of ADHD and bipolar disorder as a minor.

Free Risperdal Lawsuit Evaluation: If you or a loved one was injured by Risperdal, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against Johnson & Johnson and we can help.

Lawsuit Alleges Risperdal Caused Gynecomastia, J&J Knew Risks

The complaint, which was filed March 27 in U.S. District Court for the Eastern District of Louisiana, alleges that the plaintiff was prescribed either Risperdal, Risperdal Consta, Invega, and/or Risperidone from 2011 to 2012, and that one of these medications caused him to develop gynecomastia and other serious side effects.

The lawsuit further contends that the defendants marketed their drugs as safe and effective to treat schizophrenia and bipolar disorder, and that they “illegally promoted” them for unapproved purposes. Additionally, the suit alleges that the defendants knew about the gynecomastia risks associated with their medications, but did not disclose them.

Defendants Accused of ‘Off-Label’ Marketing

The U.S. Food & Drug Administration (FDA) approved Risperdal for use on pediatric patients with schizophrenia in 2006, and for minors with bipolar disorder in 2007. However, in many cases the defendants marketed the drug to patients in these age groups before it was legal to do so, without disclosing the gynecomastia risk.

Bellwether Trial Ends with Settlement

The first Risperdal bellwether trial to go to court resulted in a $2.5 million award for plaintiff Austin Pledger. According to the complaint, Pledger was first prescribed Risperdal in 2002, when he was seven years old. He used the drug until 2006, and allegedly developed size 44 DD breasts as a result. Risperdal was not approved for use in children at that time.

Johnson & Johnson “hid data from the FDA, prescribing doctors and parents. Documents showed they knew there was much higher percentage of children getting gynecomastia than they admitted,” according to the lawsuit (Case No. A-196444).

Do I Have a Risperdal Lawsuit?

The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Risperdal lawsuits. We are handling individual litigation nationwide and currently accepting new Risperdal gynecomastia cases in all 50 states.

Free Risperdal Lawsuit Evaluation: If you or a loved one has been injured by Risperdal, you should contact our law firm immediately. You may be entitled to compensation by filing a Risperdal injury suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*
Awards & recognition